相关实验视频

Updated: Jul 7, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

贝利穆马布在活跃狼患者中的实际有效性

Yuya Sumichika¹, Shuhei Yoshida¹, Eiji Suzuki²

¹Department of Rheumatology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Fukushima, Japan.

Journal of clinical medicine

|December 23, 2023

概括

贝利马布 (BLM) 在全身性红斑狼 (SLE) 患者中有效降低了疾病活性和普得尼松剂量. 现实世界的数据表明,BLM是适度至高SLE的可行治疗选择,与其他疗法相比.

科学领域:

免疫学免疫学免疫学
类风湿病学类风湿病学
药理学药理学是指药理学的学科.

背景情况:

系统性红斑狼 (SLE) 是一种慢性自身免疫性疾病,需要有效的治疗,以适度至高的疾病活性.
传统疗法可能存在局限性,需要对比利穆马布 (BLM) 等新药进行评估.

研究的目的:

评估贝利马布 (BLM) 在日本中度至高SLE疾病活性患者的实际有效性和安全性.
为了比较BLM对mycophenolate mofetil (MMF) 和静脉注射环胺 (IV-CY) 的疗效.

主要方法:

对129名日本SLE患者进行了回顾性队列研究,这些患者接受了BLM,MMF或IV-CY的治疗.
分析了临床结果,包括无发作生存率,SLE疾病活动指数2000 (SLEDAI-2K) 评分,以及与普雷尼松相当的剂量.
倾向性得分匹配分析被用来比较BLM与IV-CY.

主要成果:

在52周内,贝利马布显著降低了平均SLEDAI-2K得分的49.2%,每日剂量普雷尼松的21.9%.
在BLM和MMF组之间没有观察到无爆发生存率或SLEDAI-2K减少的显著差异.
对比分析显示,在BLM和IV-CY治疗患者之间,无发作生存率或SLEDAI-2K下降率没有显著差异.

结论:

贝利马布在减少现实世界SLE患者的疾病活动和皮质类固醇负担方面表现出显著的有效性.
对于中度至高度的SLE活动来说,BLM是一种有希望的替代治疗方法,特别是当传统疗法不足时.
在这个患者队列中,BLM的有效性似乎与MMF和IV-CY相美.

关键词:

贝利姆巴姆巴姆是什么意思静脉内注射的环胺基.基酸莫菲蒂尔是什么系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.

更多相关视频

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...